These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9449568)

  • 21. Capillary electrophoresis with laser-induced fluorescence detection, an adequate alternative to high-performance liquid chromatography, for the determination of ciprofloxacin and its metabolite desethyleneciprofloxacin in human plasma.
    Bannefeld KH; Stass H; Blaschke G
    J Chromatogr B Biomed Sci Appl; 1997 May; 692(2):453-9. PubMed ID: 9188836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of the new fluoroquinolone balofloxacin and its metabolites in biological fluids by high performance liquid chromatography.
    Nakagawa T; Ishigai M; Hiramatsu Y; Kinoshita H; Ishitani Y; Ohkubo K; Okazaki A
    Arzneimittelforschung; 1995 Jun; 45(6):716-8. PubMed ID: 7646578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simple high-performance liquid chromatographic assay for the determination of ciprofloxacin in human plasma with ultraviolet detection.
    Maya MT; Gonçalves NJ; Silva NB; Morais JA
    J Chromatogr B Biomed Sci Appl; 2001 May; 755(1-2):305-9. PubMed ID: 11393718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of NVP-BEZ235, a dual PI3K and mTOR inhibitor, in human and mouse plasma and in mouse tissue homogenates by reversed-phase high-performance liquid chromatography with fluorescence detection.
    Lin F; Chandrasekaran G; de Gooijer MC; Beijnen JH; van Tellingen O
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jul; 901():9-17. PubMed ID: 22727754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: tissue distribution in male rats.
    Siefert HM; Kohlsdorfer C; Steinke W; Witt A
    J Antimicrob Chemother; 1999 May; 43 Suppl B():61-7. PubMed ID: 10382877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of grepafloxacin in plasma and urine by a simple and rapid high-performance liquid chromatographic method.
    Kamberi M; Kamberi P; Nakano S
    J Chromatogr B Biomed Sci Appl; 2000 May; 741(2):295-300. PubMed ID: 10872599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of angiotensin II receptor antagonist (E4177) in human plasma and urine by high-performance liquid chromatography.
    Seki T; Yamazaki K; Kayano M
    J Chromatogr B Biomed Sci Appl; 1997 Jan; 688(1):101-6. PubMed ID: 9029319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the influence of antacids and H2 antagonists on the absorption of moxifloxacin after oral administration of a 400mg dose to healthy volunteers.
    Stass H; Böttcher MF; Ochmann K
    Clin Pharmacokinet; 2001; 40 Suppl 1():39-48. PubMed ID: 11352441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Separation of levofloxacin, ciprofloxacin, gatifloxacin, moxifloxacin, trovafloxacin and cinoxacin by high-performance liquid chromatography: application to levofloxacin determination in human plasma.
    Liang H; Kays MB; Sowinski KM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 May; 772(1):53-63. PubMed ID: 12016015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single- and multiple-dose pharmacokinetics of oral moxifloxacin and clarithromycin, and concentrations in serum, saliva and faeces.
    Burkhardt O; Borner K; Stass H; Beyer G; Allewelt M; Nord CE; Lode H
    Scand J Infect Dis; 2002; 34(12):898-903. PubMed ID: 12587622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of sparfloxacin in plasma and urine by a simple and rapid liquid chromatographic method.
    Kamberi M; Kamberi P; Hajime N; Uemura N; Nakamura K; Nakano S
    Ther Drug Monit; 1999 Aug; 21(4):411-5. PubMed ID: 10442694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimization and validation of the direct HPLC method for the determination of moxifloxacin in plasma.
    Laban-Djurdjević A; Jelikić-Stankov M; Djurdjević P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Nov; 844(1):104-11. PubMed ID: 16890030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of a new fluoroquinolone antimicrobial agent, (S)-10-[(S)-(8-amino-6-azaspiro d3,4]octan-6-yl)]-9-fluoro-2, 3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6- carboxylic acid hemihydrate, DV-7751a, in human serum and urine using solid-phase extraction and high-performance liquid chromatography with fluorescence detection.
    Tanaka M; Oshima Y; Aoki H; Hakusui H
    J Chromatogr B Biomed Appl; 1995 Feb; 664(2):401-7. PubMed ID: 7780593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of OPC-17116, a new fluoroquinolone, in human alveolar macrophages and other biological matrices by high performance liquid chromatography (HPLC).
    Woodcock JM; Andrews JM; Honeybourne D; Wise R
    FEMS Microbiol Lett; 1994 Jun; 119(3):315-20. PubMed ID: 8050712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of a MLC method with fluorescence detection for the determination of quinolones in urine samples by direct injection.
    Rambla-Alegre M; Esteve-Romero J; Carda-Broch S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Dec; 877(31):3975-81. PubMed ID: 19854116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simultaneous quantification of linezolid, tinidazole, norfloxacin, moxifloxacin, levofloxacin, and gatifloxacin in human plasma for therapeutic drug monitoring and pharmacokinetic studies in human volunteers.
    Helmy SA
    Ther Drug Monit; 2013 Dec; 35(6):770-7. PubMed ID: 24061442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simple and rapid liquid chromatography method for determination of moxifloxacin in plasma.
    Hemanth Kumar AK; Ramachandran G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Apr; 877(11-12):1205-8. PubMed ID: 19286427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of linezolid in human serum by reversed-phase high-performance liquid chromatography with ultraviolet and diode array detection.
    Cios A; Kuś K; Szymura-Oleksiak J
    Acta Pol Pharm; 2013; 70(4):631-41. PubMed ID: 23923387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analytical procedure for the determination of rufloxacin, a new pyridobenzothiazine, in human serum and urine by high-performance liquid chromatography.
    Carlucci G; Palumbo G
    J Chromatogr; 1991 Mar; 564(1):346-51. PubMed ID: 1860932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-performance liquid chromatographic determination and stability of 5-(3-methyltriazen-1-yl)-imidazo-4-carboximide, the biologically active product of the antitumor agent temozolomide, in human plasma.
    Kim HK; Lin CC; Parker D; Veals J; Lim J; Likhari P; Statkevich P; Marco A; Nomeir AA
    J Chromatogr B Biomed Sci Appl; 1997 Dec; 703(1-2):225-33. PubMed ID: 9448080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.